Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.30 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.30 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL20743591 | 0.91 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2LMNAHPGDCYP1A2 | |
| SCHEMBL20753267 | 0.83 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2LMNAKMT2AMEN1 | |
| Trifluoroacetic Acid SCHEMBL29019640 | 0.82 | KDM4E (0.32) | ALDH1A1KDM4E | |
| Trifluoroacetic Acid SCHEMBL20744248 | 0.82 | CYP2A6 (0.31) | — | |
| SCHEMBL20753588 | 0.81 | ALDH1A1 (0.39) | ALDH1A1SMN1; SMN2LMNAHPGDTSHR | |
| Bromide SCHEMBL20743531 | 0.81 | ALDH1A1 (0.39) | ALDH1A1SMN1; SMN2LMNAKMT2AMEN1 | |
| Trifluoroacetic Acid SCHEMBL20743981 | 0.81 | TSHR (0.32) | ALDH1A1HPGDTSHRKMT2AMEN1 | |
| Trifluoroacetic Acid SCHEMBL20744312 | 0.81 | ESR1 (0.30) | — | |
| SCHEMBL22350875 | 0.79 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2LMNAHPGDTSHR | |
| SCHEMBL22345285 | 0.79 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2LMNAHPGDCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220104492-A1 | PYRIDAZINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH | SYNGENTA CROP PROTECTION AG (CH) | 2022-04-07 | — | — | US | disclosed |
| EP-3924347-A1 | PYRIDAZINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH | Syngenta Crop Protection AG (CH) | 2021-12-22 | — | — | EP | disclosed |
| CN-113439081-A | Pyridazinium compounds for use in methods of controlling unwanted plant growth | 先正达农作物保护股份公司 | 2021-09-24 | — | — | CN | disclosed |
| WO-2020164973-A1 | PYRIDAZINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH | SYNGENTA CROP PROTECTION AG (CH) | 2020-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220104492-A1 | PYRIDAZINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH | DDT, PNPO, PLPBP | ALDH1A1 846/4885SMN1; SMN2 4326/4885LMNA 3695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.